- Targeting Cellular Senescence for Age-Related Diseases: Path to Clinical Translation.
- COVID-19 and cellular senescence.
- Targeting senescent cells for a healthier longevity: the roadmap for an era of global aging.
- Cellular senescence: the good, the bad and the unknown.
- Senescent Cells: A Therapeutic Target in Cardiovascular Diseases.
- Strategies for Targeting Senescent Cells in Human Disease.
- Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans.
- Impact of Geroscience on Therapeutic Strategies for Older Adults With Cardiovascular Disease: JACC Scientific Statement.
- Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy.
- Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice.
- Challenges in developing Geroscience trials.
- Targeting cellular senescence in metabolic disease.
- Cellular senescence in skin-related research: Targeted signaling pathways and naturally occurring therapeutic agents.
- Role of senescence in the chronic health consequences of COVID-19.
- Cellular senescence and senolytics: the path to the clinic.
- A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues.